Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Sucampo Pharmaceuticals, Inc.    SCMP

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Manufactures pharmaceuticals and health care products

Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products.

It operates through the following geographic segments: Asia, the Americas, and Europe.

It offers Lubiprostone, which treats chronic constipation, chronic idiopathic constipation in adults, irritable bowel syndrome with constipation in adult women, and opiod-induced constipation in adults with chronic non-cancer pain.

The company was founded by Dr. Ryuji Ueno and Dr. Sachiko Kuno on December 5, 1996 and is headquartered in Rockville, MD.

Number of employees : 139 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Pharmaceutical Products153.18100%230.06100% +50.19%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States95.7762.5%140.2461% +46.44%
Japan55.3736.1%83.1336.1% +50.13%
Rest of the World2.041.3%6.692.9% +227.75%
Managers
NameAgeSinceTitle
Peter S. Greenleaf, MBA472014Chairman & Chief Executive Officer
Peter P. Pfreundschuh MBA, CPA472017Chief Financial Officer
Peter Lichtlen MD, PhD492011Chief Medical Officer
Peter Alec Kiener, PhD642014Chief Scientific Officer
Maureen E. O'Connell, CPA552013Independent Director
John H. Johnson592014Lead Independent Director
Robert Jay Spiegel, MD662015Independent Director
Timothy P. Walbert492015Independent Director
Paul R. Edick622016Independent Director
Karen L. Smith MD, PhD492017Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 46,779,728 29,092,338 62.2% 227,266 0.5% 62.2%
Shareholders
NameEquities%
Ryuji Ueno, MD, PhD 9,080,059 19.5%
Sachiko Kuno, PhD 8,353,204 17.9%
BlackRock Fund Advisors 3,612,634 7.76%
Krensavage Asset Management LLC 2,819,708 6.06%
LSV Asset Management 2,390,418 5.13%
The Vanguard Group, Inc. 1,646,348 3.54%
Dimensional Fund Advisors LP 1,570,172 3.37%
New Enterprise Associates LLC 1,258,507 2.70%
Royce & Associates LP 1,067,923 2.29%
Millennium Management LLC 1,011,477 2.17%
Company contact information
Sucampo Pharmaceuticals, Inc.
805 King Farm Boulevard
Suite 550
Rockville, MD 20850

Phone : +1.301.961.3400
Fax : +1.301.961.3440
Web : www.sucampo.com
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
SUCAMPO PHARMACEUTICALS, INC.-24.72%475
GILEAD SCIENCES11.73%104 487
REGENERON PHARMACEUTICALS19.69%47 079
VERTEX PHARMACEUTICALS110.07%39 018
ACTELION23.81%29 869
GENMAB14.75%12 912
EXELIXIS, INC.84.17%8 091
BIOVERATIV INC0.00%6 498
BLUEBIRD BIO INC125.45%6 341
TESARO INC-14.11%6 155
TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.-0.14%5 655
NEUROCRINE BIOSCIENCES, INC.52.35%5 242
JUNO THERAPEUTICS INC130.24%4 810
HUALAN BIOLOGICAL ENGINEERING INC--.--%4 035
CLOVIS ONCOLOGY INC77.22%3 848
PEPTIDREAM INC-42.85%3 745
BEIGENE LTD (ADR)177.44%3 742
BIOCON LTD22.47%3 524
AGIOS PHARMACEUTICALS INC66.76%3 368
SAREPTA THERAPEUTICS INC87.46%3 308
AVEXIS INC112.07%3 231
Connections : Sucampo Pharmaceuticals, I
Horizon Pharmaceutical LLC
Biotechnology Innovation Organization
Cortendo AB
TetraGenetics, Inc.
Chicagonext
Cempra Pharmaceuticals, Inc.
Swiss Association of Pharmaceutical Professionals, Inc.
Pharmaceutical Research & Manufacturers of America
The Arthritis Foundation
Hyperion Therapeutics, Inc.
VirMedica, Inc.
The W2O Group
Weill Cornell Medical College
Resolve Therapeutics LLC
Horizon Pharma USA, Inc.
Cue Biopharma, Inc.
Scholastic, Inc.
Sucampo AG
Illinois Biotechnology Industry Organization
Illinois Innovation Council
World Business Chicago
Vicuron Pharmaceuticals, Inc.
MATTER Chicago
FMH Swiss Medical Association
Xeris Pharmaceuticals, Inc.
Numab AG
Iterum Therapeutics Ltd.
Avior Computing Corp.
Spiegel Consultants, LLC
NexImmune, Inc.
3G Advisors LLC
Maryland Venture Fund
Vidac Pharma Ltd.
© 2017 People , Fundamentals and Ownership